Scarring in the heart - A reversible phenomenon?

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

A recent study shows that fibroblasts that promote cardiac fibrosis are derived from the endothelium. Transforming growth factor β1 drives their derivation, whereas bone morphogenic protein 7 represses it.

Original languageEnglish (US)
Number of pages1
JournalNew England Journal of Medicine
Volume357
Issue number17
DOIs
StatePublished - Oct 25 2007
Externally publishedYes

Fingerprint

Transforming Growth Factors
Endothelium
Cicatrix
Fibrosis
Fibroblasts
Bone and Bones
Proteins

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Scarring in the heart - A reversible phenomenon? / Towbin, Jeffrey.

In: New England Journal of Medicine, Vol. 357, No. 17, 25.10.2007.

Research output: Contribution to journalArticle

@article{e1516aba7c764893b805ceff820c37a6,
title = "Scarring in the heart - A reversible phenomenon?",
abstract = "A recent study shows that fibroblasts that promote cardiac fibrosis are derived from the endothelium. Transforming growth factor β1 drives their derivation, whereas bone morphogenic protein 7 represses it.",
author = "Jeffrey Towbin",
year = "2007",
month = "10",
day = "25",
doi = "10.1056/NEJMcibr075397",
language = "English (US)",
volume = "357",
journal = "New England Journal of Medicine",
issn = "0028-4793",
publisher = "Massachussetts Medical Society",
number = "17",

}

TY - JOUR

T1 - Scarring in the heart - A reversible phenomenon?

AU - Towbin, Jeffrey

PY - 2007/10/25

Y1 - 2007/10/25

N2 - A recent study shows that fibroblasts that promote cardiac fibrosis are derived from the endothelium. Transforming growth factor β1 drives their derivation, whereas bone morphogenic protein 7 represses it.

AB - A recent study shows that fibroblasts that promote cardiac fibrosis are derived from the endothelium. Transforming growth factor β1 drives their derivation, whereas bone morphogenic protein 7 represses it.

UR - http://www.scopus.com/inward/record.url?scp=35548968013&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=35548968013&partnerID=8YFLogxK

U2 - 10.1056/NEJMcibr075397

DO - 10.1056/NEJMcibr075397

M3 - Article

VL - 357

JO - New England Journal of Medicine

JF - New England Journal of Medicine

SN - 0028-4793

IS - 17

ER -